Search hospitals
>
Michigan
>
Muskegon
Mercy Health Mercy Campus
Claim this profile
Muskegon, Michigan 49444
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Ovarian Cancer
316 reported clinical trials
1 medical researcher
Summary
Mercy Health Mercy Campus is a medical facility located in Muskegon, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Ovarian Cancer and other specialties. Mercy Health Mercy Campus is involved with conducting 316 clinical trials across 467 conditions. There are 1 research doctors associated with this hospital, such as Kathleen J. Yost.
Area of expertise
Breast Cancer
Mercy Health Mercy Campus has run 64 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Mercy Health Mercy Campus has run 48 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Clinical Trials running at Mercy Health Mercy Campus
Breast Cancer
Lung Cancer
Breast cancer
Cancer
Ovarian Cancer
Melanoma
Bladder Cancer
Multiple Myeloma
Non-Small Cell Lung Cancer
Cutaneous Melanoma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
Recruiting
2 awards
Phase 3
23 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting
2 awards
Phase 3
19 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting
2 awards
Phase 3
8 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mercy Health Mercy Campus?
Mercy Health Mercy Campus is a medical facility located in Muskegon, Michigan. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Ovarian Cancer and other specialties. Mercy Health Mercy Campus is involved with conducting 316 clinical trials across 467 conditions. There are 1 research doctors associated with this hospital, such as Kathleen J. Yost.
Where is Mercy Health Mercy Campus located?
**Mercy Health Mercy Campus** Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Directions: Follow signs to the hospital upon arrival at the campus.
Who should I call to ask about financial aid or insurance network?
**Mercy Health Mercy Campus Contact Information** **Financial Assistance:** - **Phone:** 855-420-7900 (Medicaid Eligibility Screening team) - **Website:** [Financial Assistance Information](http://www.mercy.net/patients-visitors/billing/financial-assistance/) **Insurance:** - **Phone:** 855-420-7900 (Customer Service team) - **Website:** [Insurance FAQs](http://www.mercy.net/patients-visitors/billing/faqs/) For billing inquiries, contact **855-732-0138** (Monday – Friday, 8:00am – 5:00pm EST).
What insurance does Mercy Health Mercy Campus accept?
Mercy Health Mercy Campus accepts a wide range of insurance plans, including commercial, Medicare, and Medicaid, from both local and national carriers. It's important to verify coverage and any restrictions with your insurance provider prior to scheduling visits and services. Note that some plans may mandate services at specific network locations, and out-of-network services could lead to denied coverage and full charge responsibility.
What awards or recognition has Mercy Health Mercy Campus received?
**Trinity Health Muskegon (Formerly Mercy Health Muskegon)** - Recognized for exceptional trauma care at the Hackley Campus. - Awarded the Center of Excellence designation by the Infectious Diseases Society of America.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.